We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Department of Justice (DOJ) has charged Indian drugmaker Glenmark Pharmaceuticals with allegedly conspiring to increase prices on the cholesterol drug pravastin. Read More
PhRMA has filed a lawsuit challenging a new Minnesota law that took effect on Wednesday that provides emergency access to long-term insulin for diabetics who cannot afford it. Read More
Drugmakers have continued to hike their drug prices during the COVID-19 crisis, increasing prices on average 23.8 percent for 245 drugs, many of which are used in COVID-19 treatments or research. Read More
At least five drug developers working on COVID-19 therapeutics and vaccines with U.S. government funding have contracts that bypass laws that ensure taxpayer-funded drugs and vaccines are affordable, a new report says. Read More
Japanese drugmaker Fujifilm is partnering with India’s Dr. Reddy’s and Dubai-based Global Response Aid (GRA) to manufacture and sell its influenza drug Avigan (favipiravir) for the treatment of COVID-19. Read More
In observance of the Independence Day holiday, Drug Industry Daily will not be published Friday, July 3. The next issue will be published Monday, July 6. Read More